Skip to main content
. 2007 Nov 20;97(12):1613–1617. doi: 10.1038/sj.bjc.6604090

Table 3. PSA and objective response (RECIST).

  No. (%)
PSA response (39 patients)
 PSA decline ⩾90% 15 37.5
  95% CI   20–51
 PSA decline ⩾50% 29 72.5
  95% CI   63–82
 PSA stabilisation 7 17.5
 PSA progression 3 7.5
     
Objective response (17 patients)
 CR 2 12
 PR 6 35
 SD 3 17
 CR+PR 8 47
  95% CI   29–65
 PD 6 35